rs766847555

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_025193.4(HSD3B7):​c.104G>A​(p.Arg35Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000698 in 1,604,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R35G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000074 ( 0 hom. )

Consequence

HSD3B7
NM_025193.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.182

Publications

1 publications found
Variant links:
Genes affected
HSD3B7 (HGNC:18324): (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7) This gene encodes an enzyme which is involved in the initial stages of the synthesis of bile acids from cholesterol and a member of the short-chain dehydrogenase/reductase superfamily. The encoded protein is a membrane-associated endoplasmic reticulum protein which is active against 7-alpha hydrosylated sterol substrates. Mutations in this gene are associated with a congenital bile acid synthesis defect which leads to neonatal cholestasis, a form of progressive liver disease. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
HSD3B7 Gene-Disease associations (from GenCC):
  • congenital bile acid synthesis defect 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1853399).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSD3B7NM_025193.4 linkc.104G>A p.Arg35Gln missense_variant Exon 2 of 7 ENST00000297679.10 NP_079469.2 Q9H2F3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSD3B7ENST00000297679.10 linkc.104G>A p.Arg35Gln missense_variant Exon 2 of 7 1 NM_025193.4 ENSP00000297679.5 Q9H2F3-1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152268
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000349
AC:
8
AN:
228952
AF XY:
0.0000401
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000307
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000587
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000744
AC:
108
AN:
1452356
Hom.:
0
Cov.:
33
AF XY:
0.0000748
AC XY:
54
AN XY:
721784
show subpopulations
African (AFR)
AF:
0.0000599
AC:
2
AN:
33362
American (AMR)
AF:
0.0000231
AC:
1
AN:
43306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25846
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39506
South Asian (SAS)
AF:
0.0000590
AC:
5
AN:
84680
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52248
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4506
European-Non Finnish (NFE)
AF:
0.0000875
AC:
97
AN:
1109000
Other (OTH)
AF:
0.0000501
AC:
3
AN:
59902
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152268
Hom.:
0
Cov.:
33
AF XY:
0.0000403
AC XY:
3
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41468
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5206
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68046
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000405
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 05, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.104G>A (p.R35Q) alteration is located in exon 2 (coding exon 1) of the HSD3B7 gene. This alteration results from a G to A substitution at nucleotide position 104, causing the arginine (R) at amino acid position 35 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
13
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
.;T;T;.
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.73
T;T;T;T
M_CAP
Uncertain
0.097
D
MetaRNN
Benign
0.19
T;T;T;T
MetaSVM
Benign
-0.54
T
MutationAssessor
Benign
1.5
L;L;.;.
PhyloP100
-0.18
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.12
N;N;.;.
REVEL
Benign
0.24
Sift
Benign
0.25
T;T;.;.
Sift4G
Benign
0.54
T;T;T;T
Polyphen
0.86
.;P;.;.
Vest4
0.12
MVP
0.79
MPC
0.32
ClinPred
0.085
T
GERP RS
0.69
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.036
gMVP
0.45
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs766847555; hg19: chr16-30997083; API